Abstract:Tetrahydropyrido [1,2-a]isoindolone derivatives are potent inhibitors of glycogen synthase kinase 3 beta (GSK3 beta) instead of homologous cyclin-dependent kinase 5 (CDK5). Molecular docking, molecular dynamics simulation, and MM/PBSA energy calculation are utilized to reveal the kinase inhibitors' selective mechanism at the molecular level for improving selectivity. Dynamic cross-correlation map (DCCM) analysis is applied to study the effect of the inhibitor on the interactions between each residue in CDK5 and GSK3 beta. The results of molecular docking indicate that the binding modes of three inhibitors with two kinases are especially similar, and residues in the binding pockets of two kinases are aligned with each other based on the sequence comparing analysis of crystal structures. The analysis of Root Mean Square Deviation (RMSD) with little fluctuation underlies the stability and reliability of systems. Its values of CDK5 (similar to 0.15 nm) are less than GSK3 beta (similar to 0.17 nm), and the inhibitor with higher value holds stronger flexibility and conformational changes of kinases. In terms of energies, the electrostatic and van der Walls energies are the major interactions for differentiating the activity between the same inhibitor and two kinases. And the polar solvation energy plays pivotal role in discriminating the selectivity of kinase inhibitor. The residue decomposition indicates that the residues Glu97 and Thr138 of GSK3 beta are the key residues for differentiating the inhibitor selectivity. On the other hand, in the aspect of inter-residue interaction in one kinase, results indicate that the dynamic correlation of residues is different during the binding process of CDK5 and GSK3 beta with inhibitors. The correlation of Thr138 in the hinge domain of GSK3 beta with that of residues Val135-Gln206 is positive, while the correlation of Gln85 and Cys83 similar to Ala150 in CDK5 is unclear, which is a key factor to distinguish inhibitor selectivity.

The Interactions Between Purine-Pyrimidine Derivatives and Cdk2 Based on Molecular Dynamic Simulation

Effect of Substituents in Different Positions of Aminothiazole Hinge-Binding Scaffolds on Inhibitor–CDK2 Association Probed by Interaction Entropy Method

An Insight into the Inhibitory Selectivity of 4-(Pyrazol- 4-Yl)-pyrimidines to CDK4 over CDK2

Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations

Free energy analysis of CDK2-inhibitor interaction

Molecular Dynamic Simulations Give Insight into the Mechanism of Binding Between 2-Aminothiazole Inhibitors and CDK5

Molecular Modeling and Molecular Dynamics Simulation Studies on Pyrrolopyrimidine-Based Α-Helix Mimetic As Dual Inhibitors of MDM2 and MDMX

Study on Selectivity of Inhibitor BD2 for PKA over PKC beta II

Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations

Molecular Principle of the Cyclin-Dependent Kinase Selectivity of 4-(Thiazol-5-yl)-2-(phenylamino) Pyrimidine-5-carbonitrile Derivatives Revealed by Molecular Modeling Studies.

Exploring the Selectivity of Tetrahydropyrido[1,2-a]isoindolone Derivatives to GSK3 beta and CDK5 by Computational Methods

Binding Mechanism of CDK5 with Roscovitine Derivatives Based on Molecular Dynamics Simulations and MM/PBSA Methods.

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Insights into the binding mechanisms of inhibitors of MDM2 based on molecular dynamics simulations and binding free energy calculations

Identification of natural marine compounds as potential inhibitors of CDK2 using molecular docking and molecular dynamics simulation approach

Binding Modes and Conformational Changes of FK506-binding Protein 51 Induced by Inhibitor Bindings: Insight into Molecular Mechanisms Based on Multiple Simulation Technologies

Understanding the Selectivity of Inhibitors Toward PI4KIIIα and PI4KIIIβ Based Molecular Modeling

Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study.

The Inhibitory Mechanism of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as Inhibitors of P21-Activated Kinase 4 through Molecular Dynamics Simulation

Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors

Synthesis, Biological Evaluation and Molecular Docking Studies of Pyrazole Derivatives Coupling with a Thiourea Moiety As Novel CDKs Inhibitors.